Based upon values corrected for cell viability, we calculated proteasome activity compared with the DMSO controls of the corresponding wells on each plate

Based upon values corrected for cell viability, we calculated proteasome activity compared with the DMSO controls of the corresponding wells on each plate. an interactive webpage to browse images and interaction profiles at http://dedomena.embl.de/PGPC. Abstract Small molecules often affect multiple targets, elicit off\target effects, and induce genotype\specific responses. Chemical genetics, the mapping of the genotype dependence of a small molecule’s effects across a broad spectrum of phenotypes can identify novel mechanisms of action. It can also reveal unanticipated effects and could thereby reduce high attrition rates of small molecule development pipelines. Here, we used high\content screening and image analysis to measure effects of 1,280 pharmacologically active compounds on complex phenotypes ML-324 in isogenic cancer cell lines which harbor activating or inactivating mutations in key oncogenic signaling pathways. Using multiparametric chemicalCgenetic conversation analysis, we observed phenotypic geneCdrug interactions for more than 193 compounds, with many affecting phenotypes other than cell growth. We created a resource termed the Pharmacogenetic Phenome Compendium (PGPC), which enables exploration of drug mode of action, detection of potential off\target effects, and the generation of hypotheses on drug combinations and synergism. For example, we demonstrate ML-324 that MEK inhibitors amplify the viability effect of the clinically used anti\alcoholism drug disulfiram and show that this EGFR inhibitor tyrphostin AG555 has off\target activity around the proteasome. Taken together, this study demonstrates how combining multiparametric phenotyping in different genetic backgrounds can be used to predict additional mechanisms of action and to reposition clinically used drugs. (\catenin), (PI3K) was deleted, leaving only the respective wild\type allele, as well as seven knockout cell lines for AKT1AKT1,and together (((and two parental HCT116 cell lines (P1 and P2). HCT116 cells were chosen as a model system since multiple well\characterized isogenic derivatives are available (Torrance mutant [mt], (HCT116 CTNNB1 wt +/mt +)), wild\type (wt) cells (HCT116 CTNNB1 wt +/mt ?) showed protrusions of the cell body, a morphology previously associated with a mesenchymal\like phenotype (Caie wt cells, and the phenoprints indicated largely comparable changes in shape. In contrast, the spindle toxin colchicine induced an apoptosis phenotype in parental HCT116 cells, whereas we observed increased sizes for the wt cells. Analogously, the histone methyltransferase inhibitor BIX01294 had a moderate impact on parental HCT116 cells, but led to decreased cell size and altered nuclear shape in wt cells (Fig?2A). Open in a separate window Figure EV2 Phenotypes of the twelve isogenic cell lines employedIsogenic KO cell lines show divergent phenotypes; actin, red; DNA, cyan. Phenoprints for the isogenic cell lines are depicted. Scale bars?=?20?m. Open in a separate window Figure 2 Quantitative analysis of phenotypic chemicalCgenetic interactions Drugs induce either convergent or divergent phenotypic alterations depending on genetic backgrounds as revealed by visual inspection. Phenotypes for parental HCT116 cells (P1; mutant (mut); HCT116 CTNNB 1 wt +/mt +) and wild\type (wt) (HCT116 CTNNB 1 wt +/mt ?) cells, that is, HCT116 cells with a knockout of the mutant allele, differ under control conditions (DMSO). Treatment with etoposide induces an increase in nuclear and cell size in both genetic backgrounds. Colchicine induces apoptosis in parental HCT116 cells and an increase in nuclear and cell size in wt (HCT116 CTNNB 1 wt +/mt ?) cells. BIX01294 moderately affects phenotypic features in parental cells, but induces cell condensation in wt (HCT116 CTNNB 1 wt +/mt ?) cells. Colchicine and BIX01294 reduce cell number independent of genotype. Colors: cyan, DNA; red, actin. Scale bars, 20?m. Quantitative analysis of chemicalCgenetic interactions across multiple phenotypic features. ChemicalCgenetic interactions were calculated for all 20 phenotypic features as described. Colchicine and BIX01294 display multiple interactions in wt (HCT116 CTNNB 1 wt +/mt ?) cells. Interactions are scaled to range of 0 to 1 1. *FDR? ?0.01, highlighted in red. Overlap of chemicalCgenetic interactions between phenotypic categories. Zero values have been omitted for better readability. Specificity and pleiotropy of geneCdrug interactions. The fraction of genetic backgrounds is shown for which compounds reveal at least one significant interaction (FDR? ?0.01). Number of interactions per genetic backgrounds. Different genotypes reveal varying numbers of interactions across the 20 phenotypic features investigated (FDR? ?0.01). Next, we calculated interaction coefficients (Horn wt cells, whereas we did not observe significant interactions affecting cell number, that is, cell proliferation and viability (FDR ?0.01, Fig?2B and Appendix?Fig S3). This indicates that geneCdrug interactions for colchicine or BIX01294 were specifically?seen in cell morphology phenotypes, while effects on cell number were independent of mutant versus wild\type genotype. Our analysis yielded a dataset,.is supported by an ERC Advanced Grant. Notes Mol Syst Biol. off\target effects, and induce genotype\specific responses. Chemical genetics, the mapping of the genotype dependence of a small molecule’s effects across a broad spectrum of phenotypes can identify novel mechanisms of action. It can also reveal unanticipated effects and could thereby reduce high attrition rates of small molecule development pipelines. Here, we used high\content screening and image analysis to measure effects of 1,280 pharmacologically active compounds on complex phenotypes in isogenic cancer cell lines which harbor activating or inactivating mutations in key oncogenic signaling pathways. Using multiparametric chemicalCgenetic interaction analysis, we observed phenotypic geneCdrug interactions for more than 193 compounds, with many affecting phenotypes other than cell growth. We created a resource termed the Pharmacogenetic Phenome Compendium (PGPC), which enables exploration of drug mode of action, detection of potential off\target effects, and the generation of hypotheses on drug combinations and synergism. For example, we demonstrate that MEK inhibitors amplify the viability effect of the clinically used anti\alcoholism drug disulfiram and show that the EGFR inhibitor tyrphostin AG555 has off\target activity on the proteasome. Taken together, this study demonstrates how combining multiparametric phenotyping in different genetic backgrounds can be used to predict additional mechanisms of action and to reposition clinically used drugs. (\catenin), (PI3K) was deleted, leaving only the respective wild\type allele, as well as seven knockout cell lines for AKT1AKT1,and together (((and two parental HCT116 cell lines (P1 and P2). HCT116 cells were chosen as a model system since multiple well\characterized isogenic derivatives are available (Torrance mutant [mt], (HCT116 CTNNB1 wt +/mt +)), wild\type (wt) cells (HCT116 CTNNB1 wt +/mt ?) showed protrusions of the cell body, a morphology previously associated with a mesenchymal\like phenotype (Caie wt cells, and the phenoprints indicated largely comparable changes in shape. In contrast, the spindle toxin colchicine induced an apoptosis phenotype in parental HCT116 cells, whereas we observed increased sizes for the wt cells. Analogously, the histone methyltransferase inhibitor BIX01294 had a moderate impact on parental HCT116 cells, but led to decreased cell size and altered nuclear shape in wt cells (Fig?2A). Open in a separate window Figure EV2 Phenotypes of the twelve isogenic cell lines employedIsogenic KO cell lines show divergent phenotypes; actin, red; DNA, cyan. Phenoprints for the isogenic cell lines are depicted. Scale ML-324 bars?=?20?m. Open in a separate window Figure 2 Quantitative analysis of phenotypic chemicalCgenetic interactions Drugs induce either convergent or divergent phenotypic alterations depending on genetic backgrounds as revealed by visual inspection. Phenotypes for parental HCT116 cells (P1; mutant (mut); HCT116 CTNNB 1 wt +/mt +) and wild\type (wt) (HCT116 CTNNB 1 wt +/mt ?) cells, that is, HCT116 cells with a knockout of the mutant allele, differ under control conditions (DMSO). Treatment with etoposide induces an increase in nuclear and cell size in both genetic backgrounds. Colchicine induces apoptosis in parental HCT116 cells and an increase in nuclear and cell size in wt (HCT116 CTNNB 1 wt +/mt ?) cells. BIX01294 moderately affects phenotypic features in parental cells, but induces cell condensation in wt (HCT116 CTNNB 1 wt +/mt ?) cells. Colchicine and BIX01294 reduce cell number independent of genotype. Colors: cyan, DNA; red, actin. Scale bars, 20?m. Quantitative analysis of chemicalCgenetic interactions across multiple phenotypic features. ChemicalCgenetic interactions were calculated for all 20 phenotypic features as described. Colchicine and BIX01294 display multiple interactions in wt (HCT116 CTNNB 1 wt +/mt ?) cells. Interactions are scaled to range of 0 to 1 1. *FDR? ?0.01, highlighted in red. Overlap of chemicalCgenetic interactions between phenotypic categories. Zero values have been omitted for better readability. Specificity and pleiotropy of geneCdrug interactions. The fraction of genetic backgrounds is demonstrated for which compounds reveal at least one significant connection (FDR? ?0.01). Quantity of relationships per genetic backgrounds. Different genotypes reveal varying numbers of.More research is needed for a fair assessment of prediction performance, since guidelines such as prediction sensitivity and specificity need to be calibrated depending on a drug’s solitary\agent activity, polypharmacology, and its interaction promiscuity (Cokol developed a multiplexing protocol that allows for the detection of seven unique cell components using six stains and imaging five channels (Gustafsdottir like a data package from www.bioconductor.org, including all natural data and analyses. the numeric features ( https://bioconductor.org/packages/devel/data/experiment/html/PGPC.html, see Code EV1). The authors are hosting an interactive webpage to browse images and interaction profiles at http://dedomena.embl.de/PGPC. Abstract Small molecules often impact multiple focuses on, elicit off\target effects, and induce genotype\specific responses. Chemical genetics, the mapping of the genotype dependence of a small molecule’s effects across a broad spectrum of phenotypes can determine novel mechanisms of action. It can also reveal unanticipated effects and could therefore reduce high attrition rates of small molecule development pipelines. Here, we used high\content testing and image analysis to measure effects of 1,280 pharmacologically active compounds on complex phenotypes in isogenic malignancy cell lines which harbor activating or inactivating mutations in important oncogenic signaling pathways. Using multiparametric chemicalCgenetic connection analysis, we observed phenotypic geneCdrug relationships for more than 193 compounds, with many influencing phenotypes other than cell growth. We produced a source termed the Pharmacogenetic Phenome Compendium (PGPC), which enables exploration of drug mode of action, detection of potential off\target effects, and the generation of hypotheses on drug mixtures and synergism. For example, we demonstrate that MEK inhibitors amplify the viability effect of the clinically used anti\alcoholism drug disulfiram and display the EGFR inhibitor tyrphostin AG555 offers Alcam off\target activity within the proteasome. Taken together, this study demonstrates how combining multiparametric phenotyping in different genetic backgrounds can be used to forecast additional mechanisms of action and to reposition clinically used medicines. (\catenin), (PI3K) was erased, leaving only the respective crazy\type allele, as well as seven knockout cell lines for AKT1AKT1,and collectively (((and two parental HCT116 cell lines (P1 and P2). HCT116 cells were chosen like a model system since multiple well\characterized isogenic derivatives are available (Torrance mutant [mt], (HCT116 CTNNB1 wt +/mt +)), crazy\type (wt) cells (HCT116 CTNNB1 wt +/mt ?) showed protrusions of the cell body, a morphology previously associated with a mesenchymal\like phenotype (Caie wt cells, and the phenoprints indicated mainly comparable changes in shape. In contrast, the spindle toxin colchicine induced an apoptosis phenotype in parental HCT116 cells, whereas we observed improved sizes for the wt cells. Analogously, the histone methyltransferase inhibitor BIX01294 experienced a moderate impact on parental HCT116 cells, but led to decreased cell size and modified nuclear shape in wt cells (Fig?2A). Open in a separate window Number EV2 Phenotypes of the twelve isogenic cell lines employedIsogenic KO cell lines display divergent phenotypes; actin, reddish; DNA, cyan. Phenoprints for the isogenic cell lines are depicted. Level bars?=?20?m. Open in a separate window Number 2 Quantitative analysis of phenotypic chemicalCgenetic relationships Medicines induce either convergent or divergent phenotypic alterations depending on genetic backgrounds as exposed by visual inspection. Phenotypes for parental HCT116 cells (P1; mutant (mut); HCT116 CTNNB 1 wt +/mt +) and crazy\type (wt) (HCT116 CTNNB 1 wt +/mt ?) cells, that is, HCT116 cells having a knockout of the mutant allele, differ under control conditions (DMSO). Treatment with etoposide induces an increase in nuclear and cell size in both genetic backgrounds. Colchicine induces apoptosis in parental HCT116 cells and an increase in nuclear and cell size in wt (HCT116 CTNNB 1 wt +/mt ?) cells. BIX01294 moderately affects phenotypic features in parental cells, but induces cell condensation in wt (HCT116 CTNNB 1 wt +/mt ?) cells. Colchicine and BIX01294 reduce cell number self-employed of genotype. Colours: cyan, DNA; reddish, actin. Scale bars, 20?m. Quantitative analysis of chemicalCgenetic relationships across multiple phenotypic features. ChemicalCgenetic relationships were calculated for those 20 phenotypic features as explained. Colchicine and BIX01294 display multiple relationships in wt (HCT116 CTNNB 1 wt +/mt ?) cells. Relationships are scaled to range of 0 to 1 1. *FDR? ?0.01, highlighted in red. Overlap of chemicalCgenetic relationships between phenotypic groups. Zero values have been omitted for better readability. Specificity and pleiotropy of geneCdrug relationships. The portion of genetic backgrounds is demonstrated for which compounds reveal at least one significant connection (FDR? ?0.01). Quantity of relationships per genetic backgrounds. Different genotypes reveal varying numbers of relationships across the 20 phenotypic features investigated (FDR? ?0.01). Next, we determined connection coefficients (Horn wt cells, whereas we did not observe significant relationships affecting cell number, that is, cell proliferation and viability (FDR ?0.01, Fig?2B and Appendix?Fig S3). This indicates that geneCdrug relationships for colchicine or BIX01294 were specifically?seen in cell morphology phenotypes, while effects on cell number were indie of mutant versus wild\type genotype. Our analysis yielded a dataset, termed the Pharmacogenetic Phenome Compendium (PGPC), comprising information on more than 300,000 drugCgeneCphenotype relationships..

Similar Posts